Broadband ultraviolet A vs. psoralen ultraviolet A in the treatment of vitiligo: a randomized controlled trial

Medhat El Mofty, Manal Bosseila, Heba M. Mashaly, Heba I. Gawdat, H. Makaly

Clinical and Experimental Dermatology · 2013 · 15 citations · 9 references

Abstract

BB-UVA at a dose of 15 J/cm(2) /session gives results for vitiligo that are comparable to PUVA, suggesting it might be useful when oral psoralens are contraindicated.

References

9